Unituxin (DINUTUXIMAB)

**Product type:** Human Prescription Drug

**Active ingredient:** DINUTUXIMAB

**Strength:** 3.5 mg/mL

**Dosage form:** Injection

**Route:** Intravenous

**Labeler:** United Therapeutics Corporation

**Marketing category:** BLA (BLA125516)

**Pharmacologic class:** Glycolipid Disialoganglioside-directed Antibody Interactions [MoA], Glycolipid Disialoganglioside-directed Antibody [EPC]